Drugs Made In America Acquisition DMIIU
NASDAQ DMIIU
$10.20 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT

Drugs Made In America Acquisition II Corp. (DMIIU) EBITDA (2025)

Drugs Made In America Acquisition (DMIIU) posted quarterly EBITDA of -$235472.0 for Q4 2025, down 51.42% quarter-over-quarter from -$155513.0 in Q3 2025.

Drugs Made In America Acquisition II Corp. (DMIIU) EBITDA (2025) Analysis & Trends

Drugs Made In America Acquisition (DMIIU) has reported EBITDA for 1 consecutive years, with -$235472.0 the latest figure, recorded in Q4 2025.

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

Historic Data

Download Data
DateValue
Dec 31, 2025 -235,472.00
Sep 30, 2025 -155,513.00